Citation Impact
Citing Papers
Characterization of the Early Events in Dengue Virus Cell Entry by Biochemical Assays and Single-Virus Tracking
2007
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
2008
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
2008
Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
2017
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Discovery of archaeal fusexins homologous to eukaryotic HAP2/GCS1 gamete fusion proteins
2022 StandoutNobel
A structural perspective of the flavivirus life cycle
2004
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Interaction of West Nile Virus with αvβ3 Integrin Mediates Virus Entry into Cells
2004
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
2005
Manipulation of cell surface macromolecules by flaviviruses
2003
Structures of immature flavivirus particles
2003
Biological activities and pharmaceutical applications of polysaccharide from natural resources: A review
2017 Standout
Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
2007
Structural basis of West Nile virus neutralization by a therapeutic antibody
2005 Nature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Parvovirus B19 Empty Capsids as Antigen Carriers for Presentation of Antigenic Determinants of Dengue 2 Virus
2006
Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus
2017
Lipid nanoparticles for mRNA delivery
2021 Standout
A Mouse Model for Studying Dengue Virus Pathogenesis and Immune Response
2009
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis
2008 StandoutNobel
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Modified mRNA Vaccines Protect against Zika Virus Infection
2017
Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus
2020 StandoutNobel
The continued threat of emerging flaviviruses
2020
Receptors and routes of dengue virus entry into the host cells
2015
Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
2010
Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
2008
Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2
2004
Structure of the dengue virus envelope protein after membrane fusion
2004 Nature
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody
2016
Strategies for development of dengue virus inhibitors
2010
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Molecular epidemiology of dengue in the Pacific: introduction of two distinct strains of dengue virus type-1 into Hawaii
2006
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus
2003
Recent advances in mRNA vaccine technology
2020 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Dengue: a continuing global threat
2010 Standout
A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
2009
Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus Transmission
2010 Standout
Flavivirus Structure and Membrane Fusion
2003
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
A toggle switch controls the low pH-triggered rearrangement and maturation of the dengue virus envelope proteins
2014
Mapping the Structure and Function of the E1 and E2 Glycoproteins in Alphaviruses
2006
Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses
2010
Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
2008
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins
2003
Role of antibodies in controlling dengue virus infection
2009
Dengue
2012 Standout
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
2009
Relating structure to evolution in class II viral membrane fusion proteins
2014
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody
2009
Generation of a reporter yellow fever virus for high throughput antiviral assays
2020 StandoutNobel
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes
2007
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
2010
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants
2005
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
Dissecting the Cell Entry Pathway of Dengue Virus by Single-Particle Tracking in Living Cells
2008
Antibody-mediated neutralization of flaviviruses: A reductionist view
2011
Realizing the potential of electron cryo-microscopy
2004 StandoutNobel
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
2007
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
2010
Dissection of Antibody Specificities Induced by Yellow Fever Vaccination
2013
Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga
2008
Prospects for a dengue virus vaccine
2007
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Replication of hepatitis C virus
2007 StandoutNobel
Dengue
2007 Standout
The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis
2017
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Crystal Structure of the West Nile Virus Envelope Glycoprotein
2006
Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo
2008
Identification of Neutralizing Epitopes within Structural Domain III of the West Nile Virus Envelope Protein
2002
Serotype-Specific Entry of Dengue Virus into Liver Cells: Identification of the 37-Kilodalton/67-Kilodalton High-Affinity Laminin Receptor as a Dengue Virus Serotype 1 Receptor
2004
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Bovine Viral Diarrhea Virus Core Is an Intrinsically Disordered Protein That Binds RNA
2007 StandoutNobel
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Heat Shock Protein 90 and Heat Shock Protein 70 Are Components of Dengue Virus Receptor Complex in Human Cells
2005
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
The Human Antibody Response to Dengue Virus Infection
2011
Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein
2006
On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes
2009
Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication
2016 StandoutNobel
Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae
2010 Standout
Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway
2004
Air temperature optimisation for humidity‐controlled cold storage of the predatory mites Neoseiulus californicus and Phytoseiulus persimilis (Acari: Phytoseiidae)
2013 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
2010
Chemical Structures and Bioactivities of Sulfated Polysaccharides from Marine Algae
2011 Standout
Artificial Receptors in Serologic Tests for the Early Diagnosis of Dengue Virus Infection
2006
Insect parasitoids cold storage: A comprehensive review of factors of variability and consequences
2011
Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus
2007
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
2016
Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion
2006
Marine Polysaccharides from Algae with Potential Biomedical Applications
2015 Standout
The Rosetta All-Atom Energy Function for Macromolecular Modeling and Design
2017 StandoutNobel
Functional Requirements of the Yellow Fever Virus Capsid Protein
2007
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
2006
A ligand-binding pocket in the dengue virus envelope glycoprotein
2003
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
2007
Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones
2014
Correlates of Protection Induced by Vaccination
2010 Standout
Works of Wayne Crill being referenced
Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
2001
Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement
2012
Sculpting humoral immunity through dengue vaccination to enhance protective immunity
2012
Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens
2009
Differentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-Reactivity
2007
Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes
2004
A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles
2007
Enzyme-Linked Immunosorbent Assays Using Novel Japanese Encephalitis Virus Antigen Improve the Accuracy of Clinical Diagnosis of Flavivirus Infections
2008
Within- and Between-Generation Effects of Temperature on the Morphology and Physiology of Drosophila melanogaster
1996